White Papers

GLP-1s are Changing Americans’ Bodies–But Not in the Way You Think

02/11/2026

Demand for GLP-1 agonists has been steadily climbing. From 2019 to 2023, the number of patients without diabetes who started GLP-1 treatment for obesity rose 700%; and demand for these ‘miracle’.

Weight Health at One Year: Outcomes from Omada's Enhanced GLP-1 Care Track

01/08/2026

Medication therapy and lifestyle support go hand in hand in obesity care, especially when we consider GLP-1s. The Omada Insights Lab evaluated outcomes in the Enhanced GLP-1 Care Track at one year,.

Weight Maintenance Is Possible After GLP-1s—With the Right Support

09/05/2025

Though evidence shows that GLP-1s are highly effective for weight loss, maintaining outcomes after GLP-1 discontinuation can be a struggle. Clinical trials indicate that people often regain a.

Webinars & Events

Health Evolution Summit 2026: Influencer Sponsor

01/27/2026

We’re proud to participate as an Influencer Sponsor at the Health Evolution Summit.Members of our leadership team including Co-founder & CEO Sean Duffy, President Wei-Li Shao, and CMO Dr. Thomas.

Sales Advantage Summit 2026: Gold Sponsor

01/27/2026

We're thrilled to announce our participation as a Gold Sponsor at the Sales Advantage Summit. This year’s theme, Stronger Together: Shaping the Future of Healthcare, aligns with our commitment to.

Omada Horizon Day - The Food Experience 2025

05/21/2025

Omada Horizon Day introduced our latest features during a 60-minute live virtual launch event. Omada Health leaders shared how we’re evolving virtual care with intelligent, human-centered solutions.

Keep Browsing

See All Posts
Become an Omada Insider
Sign Up